The T cell‐surface glycoprotein CD6 acts as a regulator of cell functions and is associated with the pathogenesis of autoimmune conditions including multiple sclerosis, rheumatoid arthritis, psoriasis, and inflammatory bowel disease [36, 37, 38, 39, 40, 41]. This evidence concerns the gene CD6 and multiple sclerosis.